Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 43598-429

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 43598-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Dimethyl Fumarate Delayed-Release Capsules 120 mg by Dr. Reddy's Laboratories Inc. The label states the product contains 14 capsules and is for oral use. Storage instructions include keeping between 15°C to 30°C and protecting from light. The label includes dosage guidance, distribution information, barcodes, and a batch issue date of 05/2020.*

FDA Label Image

Carton2 (Carton2)

Packaging label for Dimethyl Fumarate Delayed-Release Capsules 240 mg by Dr. Reddy's Laboratories Inc. The label shows the product name, strength, dosage form, and instructions to swallow the capsule whole. It contains 60 capsules per package, includes storage instructions, distributor information, NDC 43598-430-60, and a barcode.*

FDA Label Image

Container1 (Container1)

Label for Dimethyl Fumarate Delayed-Release Capsules 120 mg by Dr. Reddy's Laboratories Inc. The label states each capsule contains 120 mg dimethyl fumarate, with a 14 capsule count. Directions advise swallowing the capsule whole, one capsule twice daily. The label includes storage instructions and placeholders for lot and expiration information, with a barcode displayed.*

FDA Label Image

Container2 (Container2)

Label for Dimethyl Fumarate Delayed-Release Capsules, 240 mg, oral dosage form supplied in a container of 60 capsules. The label includes administration instructions to swallow the capsule whole, storage conditions, and manufacturer details for Dr. Reddy's Laboratories Inc. The label also features an NDC number and barcodes, with space for lot and expiration date coding.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier curve showing the percentage of subjects with confirmed progression of disability over 96 weeks. Two lines compare placebo with dimethyl fumarate 240 mg twice daily (BID). The graph indicates lower disability progression in the dimethyl fumarate group (16.4%) compared to placebo (27.1%). The x-axis represents time on study in weeks, and the y-axis shows the percentage of subjects with confirmed disability progression.*

FDA Label Image

Structure (Structure)

Chemical structure of dimethyl fumarate, showing the arrangement of carbon, oxygen, and hydrogen atoms including two ester groups and a carbon-carbon double bond.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.